IL267243A - מעכבי הפראנאז ושימוש בהם - Google Patents
מעכבי הפראנאז ושימוש בהםInfo
- Publication number
- IL267243A IL267243A IL267243A IL26724319A IL267243A IL 267243 A IL267243 A IL 267243A IL 267243 A IL267243 A IL 267243A IL 26724319 A IL26724319 A IL 26724319A IL 267243 A IL267243 A IL 267243A
- Authority
- IL
- Israel
- Prior art keywords
- heparanase inhibitors
- heparanase
- inhibitors
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
- C07D239/72—Quinazolines; Hydrogenated quinazolines
- C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662433639P | 2016-12-13 | 2016-12-13 | |
AU2017902346A AU2017902346A0 (en) | 2017-06-20 | Methods of treating ocular disorders | |
PCT/AU2017/000271 WO2018107201A1 (en) | 2016-12-13 | 2017-12-13 | Heparanase inhibitors and use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL267243A true IL267243A (he) | 2019-08-29 |
Family
ID=67148292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL267243A IL267243A (he) | 2016-12-13 | 2019-06-11 | מעכבי הפראנאז ושימוש בהם |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3555071A4 (he) |
AU (2) | AU2017376818A1 (he) |
IL (1) | IL267243A (he) |
WO (1) | WO2018107201A1 (he) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20210401803A1 (en) * | 2018-11-21 | 2021-12-30 | The University Of The West Indies | Compounds and uses thereof |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4668787A (en) * | 1985-12-20 | 1987-05-26 | Ortho Pharmaceutical Corporation | 5,6-dialkoxy-4-imino-2(1H)quinazolinone derivatives |
EP0594877A1 (en) * | 1992-10-26 | 1994-05-04 | National Science Council | Imidazo(1,2-c)quinazoline derivates as antihyper tensives and anti dysurics |
GT199900185A (es) * | 1998-11-06 | 2001-04-18 | Novedosa pirimidin-4-enamina como fungicida. | |
EP1485380B1 (en) * | 2002-03-15 | 2010-05-19 | Vertex Pharmaceuticals Incorporated | Azolylaminoazines as inhibitors of protein kinases |
US7928111B2 (en) * | 2007-06-08 | 2011-04-19 | Senomyx, Inc. | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors |
KR101646960B1 (ko) * | 2007-10-16 | 2016-08-09 | 프로젠 피지500 시리즈 피티와이 리미티드 | 신규한 황산화된 올리고사카라이드 유도체 |
-
2017
- 2017-12-13 EP EP17880657.6A patent/EP3555071A4/en not_active Withdrawn
- 2017-12-13 AU AU2017376818A patent/AU2017376818A1/en not_active Abandoned
- 2017-12-13 WO PCT/AU2017/000271 patent/WO2018107201A1/en active Search and Examination
-
2019
- 2019-06-11 IL IL267243A patent/IL267243A/he unknown
-
2022
- 2022-03-11 AU AU2022201731A patent/AU2022201731B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP3555071A4 (en) | 2020-06-10 |
AU2022201731B2 (en) | 2024-03-28 |
AU2022201731A1 (en) | 2022-04-07 |
AU2017376818A1 (en) | 2019-07-11 |
EP3555071A1 (en) | 2019-10-23 |
WO2018107201A1 (en) | 2018-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL265922A (he) | מעכבי tyk2 ושימושים בהם | |
IL266109A (he) | מעכבי tyk2 ושימושים בהם | |
HK1256997A1 (zh) | Tyk2抑制劑及其用途 | |
HK1248690A1 (zh) | 酪胺酸蛋白質激酶2(tyk2)抑制劑及其用途 | |
HK1243072A1 (zh) | 布羅莫結構域抑制劑及其用途 | |
IL267291B (he) | מעכבי אקטונוקליאוטידאז ושיטות לשימוש בהם | |
GB201605126D0 (en) | Inhibitors and their uses | |
EP3572400C0 (en) | EZH2 INHIBITOR AND ITS USE | |
IL282482A (he) | וריאנטים של פרוטוקסין–ii ושיטות לשימוש | |
HUE063120T2 (hu) | LRRC33-inhibitorok és alkalmazásuk | |
LT3532459T (lt) | Lsd1 inhibitoriai ir jų medicininis panaudojimas | |
IL282508A (he) | וריאנטים של פרוטוקסין–ii ושיטות לשימוש | |
IL267238A (he) | מעכבי הפראנאז ושימוש בהם | |
IL255530A (he) | מעכבי efflux-pump ושימושים טיפוליים בהם | |
IL251077B (he) | מעכבי אינטגרין והשימוש בהם | |
HK1250028A1 (zh) | 2-苯基-6-咪唑基-吡啶-4-甲酰胺衍生物及其作為eaat3抑制劑的用途 | |
HK1250926A1 (zh) | 抑制劑及其應用 | |
IL251078B (he) | מעכבי אינטגרין והשימוש בהם | |
HK1255029A1 (zh) | 明膠酶抑制劑及其用途 | |
IL267243A (he) | מעכבי הפראנאז ושימוש בהם | |
GB201509977D0 (en) | Dispensers and methods of use thereof | |
IL247872A0 (he) | מעכבי stat5 ושימושיהם | |
GB201505975D0 (en) | Inhibitors and their uses | |
GB201505971D0 (en) | Inhibitors and their uses | |
AU2014900775A0 (en) | Heparanase inhibitors and uses thereof |